CoChat

Complement as a regulator of adaptive immunity

Open access
Killick, Justin, Morisse, Gregoire, Sieger, Dirk, Astier, Anne L. · 2018 · Seminars in Immunopathology

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Abstract

The complement system is an ancient and evolutionarily conserved effector system comprising in mammals over 50 circulating and membrane bound proteins. Complement has long been described as belonging to the innate immune system; however, a number of recent studies have demonstrated its key role in the modulation of the adaptive immune response. This review does not set out to be an exhaustive list of the numerous interactions of the many complement components with adaptive immunity; rather, we will focus more precisely on the role of some complement molecules in the regulation of antigen presenting cells, as well as on their direct effect on the activation of the core adaptive immune cells, B and T lymphocytes. Recent reports on the local production and activation of complement proteins also suggest a major role in the control of effector responses. The crucial role of complement in adaptive immunity is further highlighted by several examples of dysregulation of these pathways in human diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00281-017-0644-y

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Complement regulation of dendritic and B cell functions. The interaction of complement component C1q with dendritic C1qR results in differential responses dependent on its ligand. C1q bound to microbial surfaces results in DC maturation, increased expression of MHC-II and CCR7, and increased secretion of IL-12p70 resulting in improved ability to present antigen, migration towards the lymphoid tissue and promotion of Th1 effector cell differentiation, respectively. However, C1q bound to apoptotic cells results in secretion of the anti-inflammatory cytokine IL-10 as opposed to IL-12p70 resulting in activation of regulatory T cells. C3b and C3d complement coated antigen is bound by antigen presenting cell surface CD21 and CD35 complement receptors, assisting in antigen uptake. The internalized antigen is degraded to antigenic peptide and presented on the surface MHC-II. B cell activation is regulated by complement C3d or C3b binding to cell surface CD21 or CD35 resulting in either a reduction in activation threshold or an inhibition of activation, respectively. Complement component C4BP interacts with a variety of ligands including complement C3b and B cell surface CD40. Interaction of C4BP with CD40 alone induces B cell activation, proliferation, and antibody class switching from IgM to IgE. However, C3b bound C4BP can bridge interactions between CD46 and CD40 which results in inhibition of CD40 mediated antibody class switching
Fig. 1 Complement regulation of dendritic and B cell functions. The interaction of complement component C1q with dendritic C1qR results in differential responses dependent on its ligand. C1q bound to microbial surfaces results in DC maturation, increased expression of MHC-II and CCR7, and increased secretion of IL-12p70 resulting in improved ability to present antigen, migration towards the lymphoid tissue and promotion of Th1 effector cell differentiation, respectively. However, C1q bound to apoptotic cells results in secretion of the anti-inflammatory cytokine IL-10 as opposed to IL-12p70 resulting in activation of regulatory T cells. C3b and C3d complement coated antigen is bound by antigen presenting cell surface CD21 and CD35 complement receptors, assisting in antigen uptake. The internalized antigen is degraded to antigenic peptide and presented on the surface MHC-II. B cell activation is regulated by complement C3d or C3b binding to cell surface CD21 or CD35 resulting in either a reduction in activation threshold or an inhibition of activation, respectively. Complement component C4BP interacts with a variety of ligands including complement C3b and B cell surface CD40. Interaction of C4BP with CD40 alone induces B cell activation, proliferation, and antibody class switching from IgM to IgE. However, C3b bound C4BP can bridge interactions between CD46 and CD40 which results in inhibition of CD40 mediated antibody class switchingCC BY · PubMed Central
Fig. 2 T cell activation induces autocrine and intracellular complement activation that regulates T cell metabolic function and inflammasome formation. T cell activation by TCR/CD28 results in the intracellular generation of C5a and the cathepsin L-mediated cleavage of intracellular C3 to C3a and C3b. Intracellular C5a activates cytosolic C5aR1, in addition to being translocated to the plasma membrane allowing interaction with the cell surface C5aR2. Activation of C5aR1 leads to an increase in intracellular ROS generation, which in turn results in the formation of the NLRP3 inflammasome complex. Activation of C5aR2 by cell secreted C5a negatively regulates this process. Lysosomes containing the C3 cleavage products C3a and C3b are shuttled to the cell membrane leading to C3a and C3b mediated autocrine activation of C3aR and CD46, respectively. Activation of cell surface C3aR results in decreased expression of the regulatory T cell transcription factor FOXP3 and increased Th1 effector functions and IFNγ secretion. Cell surface CD46 forms a complex the Notch signaling activator Jagged1. Upon interaction of C3b to CD46, CD46 extracellular region is cleaved by metalloproteases and its intracellular cytoplasmic domains further cleaved by a presenilin-gamma secretase complex. Cleavage releases Jagged1 resulting in activation of the Notch signaling pathway. Translocation of the CD46 cytoplasmic tail to the nucleus results in increased expression of GLUT1 and LAT1 nutrient transporters, mTOR, and the NLRP3 inflammasome
Fig. 2 T cell activation induces autocrine and intracellular complement activation that regulates T cell metabolic function and inflammasome formation. T cell activation by TCR/CD28 results in the intracellular generation of C5a and the cathepsin L-mediated cleavage of intracellular C3 to C3a and C3b. Intracellular C5a activates cytosolic C5aR1, in addition to being translocated to the plasma membrane allowing interaction with the cell surface C5aR2. Activation of C5aR1 leads to an increase in intracellular ROS generation, which in turn results in the formation of the NLRP3 inflammasome complex. Activation of C5aR2 by cell secreted C5a negatively regulates this process. Lysosomes containing the C3 cleavage products C3a and C3b are shuttled to the cell membrane leading to C3a and C3b mediated autocrine activation of C3aR and CD46, respectively. Activation of cell surface C3aR results in decreased expression of the regulatory T cell transcription factor FOXP3 and increased Th1 effector functions and IFNγ secretion. Cell surface CD46 forms a complex the Notch signaling activator Jagged1. Upon interaction of C3b to CD46, CD46 extracellular region is cleaved by metalloproteases and its intracellular cytoplasmic domains further cleaved by a presenilin-gamma secretase complex. Cleavage releases Jagged1 resulting in activation of the Notch signaling pathway. Translocation of the CD46 cytoplasmic tail to the nucleus results in increased expression of GLUT1 and LAT1 nutrient transporters, mTOR, and the NLRP3 inflammasomeCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 101 references

Cited by

See all 129

Metadata

Authors
Killick, J., Morisse, G., Sieger, D., & Astier, A. L.
Affiliations
  • Centre for Inflammation Research (GB)
  • University of Edinburgh (GB)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Astier, Anne L.
Venue
Seminars in Immunopathology
Published
2017-08-25
Volume
40
Issue
1
Pages
37-48
ISSN
  • 1863-2297 (ISSN-L)
  • 1863-2300
OpenAlex
W2748098899
Cited by
129
References
101
Citations by year
2026: 9 · 2025: 14 · 2024: 12 · 2023: 19 · 2022: 16 · 2021: 14 · 2020: 14 · 2019: 18 · 2018: 11 · 2017: 2
FWCI
1.26
Type
journal article
Language
en
Open access
Locations
  • Seminars in Immunopathology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
Multiple Sclerosis Society (41, 34)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
complement system, adaptive immunity, antigen-presenting cells, B cells, T cells, complement dysregulation, local complement activation
MeSH terms
Animals, Antigen-Presenting Cells, B-Lymphocytes, Carrier Proteins, Cell Communication, Complement System Proteins, Complement Activation, Disease Susceptibility, Humans, Immunologic Factors, Lymphocyte Activation, Protein Binding, T-Lymphocytes, Signal Transduction, Adaptive Immunity, Immunomodulation, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Complement as a regulator of adaptive immunity. https://app.cochat.ai/papers/10.1007/s00281-017-0644-y
The paper
Killick, J., Morisse, G., Sieger, D., & Astier, A. L. (2018). Complement as a regulator of adaptive immunity. Seminars in Immunopathology. https://doi.org/10.1007/s00281-017-0644-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.